Kentucky 2026 Regular Session

Kentucky House Bill HB895

Introduced
3/4/26  
Refer
3/4/26  

Caption

AN ACT relating to the regulation of psychoactive substances.

Impact

The introduction of HB 895 is expected to reshape the regulatory landscape for hemp in Kentucky significantly. By formalizing the licensing and regulatory framework, the bill seeks to enhance the safety and quality of hemp products available in the market. Moreover, it establishes guidelines for the testing of cannabinoid products, which should improve consumer confidence in these products and potentially foster a more regulated, safe industry. The allocation of collected fees to support education and research initiatives within hemp agriculture further underscores the bill's broader economic and public health goals.

Summary

House Bill 895, titled 'An Act relating to the regulation of psychoactive substances', aims to establish comprehensive frameworks for the regulation of hemp and cannabinoid products within the Commonwealth. This legislation focuses on creating a licensing system for businesses that cultivate, handle, process, and market hemp derivatives, ensuring that all activities are conducted in compliance with state laws and regulations. Central to this bill is the formation of the Department of Psychoactive Substances which will oversee the licensing process and the implementation of regulatory standards for testing and safety related to these products.

Sentiment

The general sentiment surrounding HB 895 appears to be supportive among industry advocates who view regulation as a way to legitimize and stabilize the hemp market in Kentucky. Supporters argue that clear guidelines and regulations are essential for the growth of the hemp industry while ensuring consumer safety. Conversely, some skepticism exists regarding the potential administrative burden that such regulations might impose on small farmers and businesses, as well as concerns about the efficacy of regulatory enforcement.

Contention

Notable points of contention include debates over the extent of regulation and the impact of licensing fees on smaller producers. While some stakeholders argue that robust regulation will protect consumers and enhance market integrity, others fear that excessive regulation could hinder the growth of small hemp enterprises due to increased costs and administrative complexities. Additionally, the balance between ensuring quality product safety and preventing overreach into the livelihoods of local hemp businesses remains a critical discussion point as the bill progresses.

Companion Bills

No companion bills found.

Previously Filed As

KY HB106

AN ACT relating to cannabis.

KY HB734

AN ACT relating to regulated beverages.

KY HB571

AN ACT relating to medicinal cannabis.

KY HB320

AN ACT relating to controlled substances.

KY HB422

AN ACT relating to administrative regulations.

KY HB63

AN ACT relating to the regulation of nicotine products.

KY HB102

AN ACT relating to perfluoroalkyl and polyfluoroalkyl substances.

KY HB389

AN ACT relating to prescription drugs.

KY SB20

AN ACT relating to administrative regulations and declaring an emergency.

KY HB6

AN ACT relating to administrative regulations and declaring an emergency.

Similar Bills

OR SB1548

Relating to marijuana; prescribing an effective date.

SC S0137

Hemp-Derived Cannabinoids

AL SB255

Cannabinoid products from hemp; sale regulated by Revenue Department, licensure required; tax imposed

SC H3601

Hemp Derived Canabis

MN SF2370

Omnibus Cannabis Policy Bill

MN HF1615

Cannabis policy bill.

NJ S2537

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

NJ A4082

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.